Meptin



Indications and Reactions:

Role Indications Reactions
Secondary
Asthma 23.6%
Cough 12.1%
Drug Use For Unknown Indication 11.5%
Pneumonia 6.1%
Upper Respiratory Tract Infection 5.5%
Bronchitis 4.8%
Hyperlipidaemia 3.6%
Nausea 3.6%
Interstitial Lung Disease 3.0%
Abdominal Pain Upper 2.4%
Constipation 2.4%
Hyperuricaemia 2.4%
Influenza 2.4%
Insomnia 2.4%
Intentional Overdose 2.4%
Nasal Congestion 2.4%
Osteoporosis 2.4%
Pharyngitis 2.4%
Product Used For Unknown Indication 2.4%
Cerebral Infarction 1.8%
Nasopharyngitis 9.1%
Tooth Hypoplasia 9.1%
Tremor 9.1%
Aggression 6.1%
Coma 6.1%
Hallucination, Visual 6.1%
Mumps 6.1%
Neutropenia 6.1%
Rhabdomyolysis 6.1%
Status Asthmaticus 6.1%
Altered State Of Consciousness 3.0%
Delirium 3.0%
Faeces Discoloured 3.0%
Hepatic Function Abnormal 3.0%
Hospitalisation 3.0%
Hypokalaemia 3.0%
Interstitial Lung Disease 3.0%
Liver Disorder 3.0%
Palpitations 3.0%
Tachycardia 3.0%
Concomitant
Product Used For Unknown Indication 28.9%
Asthma 27.3%
Bronchitis 9.0%
Drug Use For Unknown Indication 5.6%
Upper Respiratory Tract Inflammation 4.5%
Pneumonia 3.2%
Chronic Obstructive Pulmonary Disease 2.7%
Hypertension 2.7%
Prophylaxis 2.5%
Otitis Media 2.1%
Influenza 1.6%
Rheumatoid Arthritis 1.4%
Rhinitis 1.3%
Tonsillitis 1.3%
Nasopharyngitis 1.2%
Insomnia 1.2%
Gastritis 0.9%
Diabetes Mellitus 0.9%
Psoriatic Arthropathy 0.9%
Cardiac Failure 0.9%
Asthma 29.2%
Pneumonia 8.8%
Interstitial Lung Disease 6.5%
White Blood Cell Count Decreased 5.6%
Rhabdomyolysis 4.6%
Vomiting 4.2%
Abnormal Behaviour 3.7%
Dyspnoea 3.7%
Drug Eruption 3.2%
Nasopharyngitis 3.2%
Pyrexia 3.2%
Septic Shock 3.2%
Death 2.8%
Hypoaesthesia 2.8%
Liver Disorder 2.8%
Respiratory Arrest 2.8%
Wheezing 2.8%
Hypoglycaemia 2.3%
Loss Of Consciousness 2.3%
Pneumonia Bacterial 2.3%
Interacting
Bronchitis 100.0%
Ventricular Extrasystoles 100.0%